According to a recent Future Industry Insights (FMI) report, the dosimetry market sale would generate revenues exceeding US$ 4.3 billion by 2029 as a result of growing adoption at different healthcare facilities.
The use of dosimetry has been spurred by stringent government restrictions pertaining to radiation toxicity limits, an increasing understanding of the detrimental effects of radiation, and growing concerns regarding the health of workers in workplaces where radiation exposure occurs.
Rising adoption of radiopharmaceuticals used for diagnostic purposes can increase the radiation levels in hospitals. This has, in turn, increased the risk of radiation-related diseases among healthcare professionals. There has been a rise in the adoption of wearable dosimeters by hospitals to analyse radiation levels among their staff, which has created opportunity for the growth of the dosimetry market.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-3482
Key Takeaways :
•The adoption of personal electronic dosimeters for real-time monitoring is expected to gain traction, and contribute more than 60% of revenue share during the forecast period.
•Growing adoption of wearable dosimeters by hospital professionals to analyse radiation levels is expected to contribute to the significant revenue share of the segment.
•Passive dosimeters dominate the market by energy, as these are relatively cheaper than active dosimeters.
•In terms of end user, industrial and medical are expected to collectively gain more than 40% of market share during the forecast period.
•North America is the leading market, while the dosimetry market in South Asia is expected to grow at significant rate, owing to increasing healthcare infrastructure and industrialization.
Acquisition Key Strategy Followed by Leading Manufacturers.The global Dosimetry Market is expected to reach US$ 2.7 Billion in 2022, with a CAGR of 6.8% indicating positive market growth over the forecast period.
According to Future Market Insights, the Wearable Dosimetry by Modality market is expected to reach US$ 1.8 Billion in 2022, accounting for more than half of the total dosimetry market..
Want more insights on the dosimetry market?
A new study by Future Market Insights opines on the evolution of the dosimetry market from 2014 to 2021, and presents demand projections for 2022 to 2029, on the basis of product (personal electronic dosimeters, self-reading dosimeters, processed dosimeters), modality (wearable and non-wearable), energy (active dosimeters and passive dosimeters), and end user (industrial, medical, oil and gas, defence, homeland security, mining, environmental, others), across seven prominent regions.
Key Companies:
- Honeywell
- Fisher Scientific Inc.
- Landauer, Inc. (Fortive)
- Mirion Technologies Inc.
- Fuji Electric Corporation of America
- Polimaster Inc.
- JP Laboratories Inc.
- X-Z Lab Inc.
- Ludlum Measurements Inc
- Laurus Systems Inc.
- Far West Technology Inc.
- S.E. International Inc.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-3482
Dosimetry Market by Category
By Product Type :
- Personal Electronic Dosimeter
- Self-reading Dosimeters
- Processed Dosimeters
By Modality :
- Wearable
- Collar level
- Chest level
- Waist level
- Wrist level
- Finger level
- Non-wearable
By Energy :
- Active Dosimeters
- Passive Dosimeters
- Optically Stimulated Luminescence Dosimeter (OSLD)
- Thermoluminescence Dosimeters (TLD)
- Radiophotoluminescence (RPL)
By End User :
- Industrial
- Medical
- Oil and Gas
- Defense, Homeland Security
- Mining
- Environmental
- Others
By Region :
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle-East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
